Twist Bioscience Revolutionizes Next-Generation Sequencing with IVDR Compliant Precision Dx Products

  The newly unveiled suite of Precision Dx Products includes the Twist Precision Prep and Enrichment Dx Kit, the Twist Precision Exome Dx Panel, and ...

March 07, 2024 | Thursday | News
Alamar Biosciences Partners with ALZpath to Advance Alzheimer's Diagnostic Solutions

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic supply agreemen...

March 04, 2024 | Monday | News
Biocon Biologics Gains Rights to Launch Stelara® Biosimilar in the US by 2025 Following Janssen Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced...

March 04, 2024 | Monday | News
BeiGene Reports BRUKINSA® Outperforms Acalabrutinib in Chronic Leukemia Study

BeiGene, Ltd. announced a new matching adjusted indirect comparison (MAIC) of the efficacy of BRUKINSA® (zanubrutinib) versus acalabrutinib in relapsed...

March 01, 2024 | Friday | News
Applied Biomics Launches Anti-Host Cell Protein (HCP) Antibodies with > 95% Coverage

The residual HCPs are generated by organisms used for making recombinant biopharmaceutical products. They are considered as process-related impurities. Sin...

March 01, 2024 | Friday | News
AbbVie and OSE Immunotherapeutics Forge Partnership to Develop Breakthrough Chronic Inflammation Treatment

Global license and collaboration agreement set to advance the development of OSE-230, a monoclonal antibody aimed at resolving chronic inflammation. ...

February 28, 2024 | Wednesday | News
Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Elevating Single Cell Sequencing Solutions

Parse Biosciences, a pioneering provider of accessible and scalable single cell sequencing solutions, has announced a significant update to its flagship Ev...

February 22, 2024 | Thursday | News
LimmaTech Biologics Announces Positive Interim Results for Shigella4V Vaccine in Phase I/II Trial

LimmaTech Biologics AG, announced encouraging interim results from its Phase I/II clinical trial evaluating Shigella4V (S4V), a promising tetravalent bioco...

February 22, 2024 | Thursday | News
Biocytogen Pharmaceuticals Announces Antibody Evaluation and Option Agreement with Gilead Sciences

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315)  announces an antibody evaluation and option agreement with Gil...

February 20, 2024 | Tuesday | News
Biocon Biologics and Sandoz Australia Forge Partnership for Biosimilars Trastuzumab and Bevacizumab

Biocon Biologics Ltd (BBL), a leading biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), has announced a significant five-ye...

February 09, 2024 | Friday | News
Purolite & Repligen Launch New CH1 Affinity Resin for Specialized mAb Purification

This latest innovation, which was developed for commercialization by Purolite as part of a multi-year strategic partnership with Repligen, combines Purolit...

February 06, 2024 | Tuesday | News
Twist Bioscience Expands Express Genes Rapid Synthesis Service

The Express Genes offering, initially launched in November 2023, now extends to larger midiprep (10μg to 100 μg) and maxiprep (100μg to 1mg) DNA p...

February 05, 2024 | Monday | News
Revvity Introduces Cutting-Edge Solutions for Diagnostics and Life Sciences at SLAS2024

 The company's commitment to advancing human potential through science is evident in its transformative approach and a diverse portfolio of specialize...

February 05, 2024 | Monday | News
RevoluGen and LGC Biosearch Showcase Advanced DNA Extraction with Fire Monkey Chemistry

Under a collaboration with LGC Biosearch TechnologiesTM, RevoluGen has coupled its Fire Monkey chemistry with LGC magnetic beads and LGC oKtopureTM liquid ...

January 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close